Novo Nordisk – Global Leader in Diabetes and Obesity Care

Novo Nordisk

Novo Nordisk is a leading global pharmaceutical company founded in 1923 and headquartered in Denmark. The manufacturer is a recognized global leader in diabetes care, possessing the most comprehensive portfolio of modern insulins and delivery systems. The company also specializes in innovative solutions for obesity management, haemophilia, and growth disorders. Novo Nordisk products combine impeccable European quality with a century of scientific breakthroughs, helping millions of people manage serious chronic conditions.